Vinayak Doraiswamy Atri Cure, Inc. (ATRC) insider trading activity
Vinayak Doraiswamy is Chief Scientific Officer of AtriCure, Inc.. Currently has a direct ownership of 74,372 shares of ATRC, which is worth approximately $2.21 Million. The most recent transaction as insider was on Jun 30, 2025, when has been sold 822 shares (Common Stock) at a price of $25.84 per share, resulting in proceeds of $21,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
74.4K
2.21%
3M change
24.4%
12M change
Total Value Held
$2.21 Million
Vinayak Doraiswamy Transaction History
VD
Vinayak Doraiswamy
Chief Scientific Officer
Mason, OH